A share price of Integra Lifesciences Holdings Corp [IART] is currently trading at $30.61, up 4.44%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The IART shares have gain 6.54% over the last week, with a monthly amount drifted -0.13%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Integra Lifesciences Holdings Corp [NASDAQ: IART] stock has seen the most recent analyst activity on May 07, 2024, when Wells Fargo downgraded its rating to a Equal Weight and also revised its price target to $25 from $45. Previously, Oppenheimer downgraded its rating to Perform on May 07, 2024. On April 03, 2024, upgrade upgraded it’s rating to Neutral but maintained its price target of $38 on the stock. Wells Fargo upgraded its rating to a Overweight and increased its price target to $49 on December 05, 2023. CL King initiated its recommendation with a Buy and recommended $50 as its price target on November 14, 2023. Morgan Stanley downgraded its rating to Underweight for this stock on August 24, 2023, but kept the price target unchanged to $44. In a note dated July 12, 2023, Jefferies upgraded an Buy rating on this stock and revised its target price from $58 to $53.
Integra Lifesciences Holdings Corp experienced fluctuations in its stock price throughout the past year between $22.36 and $46.75. Currently, Wall Street analysts expect the stock to reach $50 within the next 12 months. Integra Lifesciences Holdings Corp [NASDAQ: IART] shares were valued at $30.61 at the most recent close of the market. An investor can expect a potential return of 63.35% based on the average IART price forecast.
Analyzing the IART fundamentals
Trailing Twelve Months sales for Integra Lifesciences Holdings Corp [NASDAQ:IART] were 1.53B which represents -3.14% decline. Gross Profit Margin for this corporation currently stands at 0.57% with Operating Profit Margin at 0.06%, Pretax Profit Margin comes in at 0.03%, and Net Profit Margin reading is 0.03%. To continue investigating profitability, this company’s Return on Assets is posted at 0.01, Equity is 0.02 and Total Capital is 0.03. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.07.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 29.60 points at the first support level, and at 28.59 for the second support level. However, for the 1st resistance point, the stock is sitting at 31.14, and for the 2nd resistance point, it is at 31.67.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Integra Lifesciences Holdings Corp [NASDAQ:IART] is 4.68. Further, the Quick Ratio stands at 3.35, while the Cash Ratio is 1.96. Considering the valuation of this stock, the price to sales ratio is 1.58, the price to book ratio is 1.51 and price to earnings (TTM) ratio is 60.39.
Transactions by insiders
Recent insider trading involved ESSIG STUART, Exec. Chairman of the Board, that happened on May 23 ’24 when 52641.0 shares were purchased. Director, HILL BARBARA B completed a deal on May 21 ’24 to buy 36350.0 shares. Meanwhile, EVP & President, TT DAVIS ROBERT T. JR. sold 8348.0 shares on Mar 06 ’24.
